HYPOTHESIS: TETRACYCLINES FOR SEVERE COVID-19 – THE PERFECT
REPURPOSING CANDIDATE?
Garrido-Mesa J*1, Adams KE2, Galvez
J3, Garrido-Mesa N4
1Department of Medical and Molecular Genetics, Faculty
of Life Sciences and Medicine, Guy’s & St Thomas’ NHS Foundation Trust
and King’s College London NIHR Biomedical Research Centre, London, UK.
2Department of Bioscience, School of Health, Sport and
Bioscience, University of East London, London, UK.
3 Department of Pharmacology, Center for Biomedical
Research (CIBM), University of Granada, AND Instituto de Investigación
Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
4Department of Pharmacy, School of Life Sciences,
Pharmacy and Chemistry. Kingston University, London, UK.
*Correspondence : Jose Garrido Mesa, PhD
Spondyloarthritis Research Group, Department of Medical & Molecular
Genetics, School of Basic and Medical Biosciences, Faculty of Life
Sciences & Medicine, King’s College London. Email:
j.garrido@kcl.ac.uk (J.
Garrido-Mesa).